4//SEC Filing
Sandison Taylor 4
Accession 0001610618-23-000032
CIK 0001610618other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:28 PM ET
Size
7.2 KB
Accession
0001610618-23-000032
Insider Transaction Report
Form 4
Sandison Taylor
Chief Medical Officer
Transactions
- Award
Common Stock
2023-03-27+90,000→ 378,550 total - Award
Employee Stock Option (right to buy)
2023-03-27+180,000→ 180,000 totalExercise: $1.01Exp: 2033-03-26→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001702287
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 5:28 PM ET
- Size
- 7.2 KB